Skip to content
Triangle logo TriangleGet started
← Cervical Cancer

HEALTH PROFESSIONAL · SOURCE READING

Pelvic exenteration

Source: Cervical Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Stage IVB and Recurrent Cervical Cancer / Treatment Options for Stage IVB and Recurrent Cervical Cancer

No standard treatment is available for patients with recurrent cervical cancer that has spread beyond the confines of a radiation or surgical field. For locally recurrent disease, pelvic exenteration can lead to 5-year survival rates of 32% to 62% in selected patients.[25,26] These patients are appropriate candidates for clinical trials testing drug combinations or new anticancer agents.

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice